Technical Analysis for SNG - Synairgen Plc

Grade Last Price % Change Price Change
F 154.6 3.07% 4.60
SNG closed up 3.07 percent on Friday, April 16, 2021, on 1.14 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat
Historical SNG trend table...

Date Alert Name Type % Chg
Multiple of Ten Bullish Other 0.00%
Outside Day Range Expansion 0.00%
New Downtrend Bearish 3.07%
Narrow Range Bar Range Contraction 3.07%
NR7 Range Contraction 3.07%
Pocket Pivot Bullish Swing Setup 1.38%
Lower Bollinger Band Walk Weakness 1.38%
Multiple of Ten Bullish Other 1.38%
Lower Bollinger Band Touch Weakness 1.38%
Fell Below 200 DMA Bearish 4.88%
Older End-of-Day Signals for SNG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Synairgen Plc Description

Synairgen plc is a holding company. The Company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). The Company uses its human biology BioBank platform to discover and develop therapies for respiratory disease. Using the BioBank platform, it has developed a number of tissue models, which include In vitro and Ex vivo models. The Company's primary asset is AZD9412, which is an inhaled interferon beta (IFN-beta) therapy. AZD9412 is outlicensed to AstraZeneca for the clinical development and commercialization, and is in a confirmatory Phase II trial. Its drug programs include IFN-b (SNG001) for Asthma and COPD, and Lysyl oxidase-like protein 2 (LOXL2) inhibitors for IPF. The Company's subsidiary includes Synairgen Research Limited, which is engaged in the drug discovery and development.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Bank Research Medicine Clinic Disease Diseases Therapy Beta Biology Rtt Respirator Therapies Drug Discovery In Vitro Respiratory Disease Chronic Obstructive Pulmonary Disease Respiratory Diseases Copd Respiratory Therapy Astrazeneca Fibrosis Asthma Chronic Lower Respiratory Diseases

Is SNG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 260.0
52 Week Low 32.712
Average Volume 1,244,842
200-Day Moving Average 158.57
50-Day Moving Average 167.86
20-Day Moving Average 158.60
10-Day Moving Average 154.89
Average True Range 9.88
ADX 26.43
+DI 11.55
-DI 25.54
Chandelier Exit (Long, 3 ATRs ) 147.04
Chandelier Exit (Short, 3 ATRs ) 168.64
Upper Bollinger Band 172.81
Lower Bollinger Band 144.38
Percent B (%b) 0.36
BandWidth 17.93
MACD Line -4.27
MACD Signal Line -3.93
MACD Histogram -0.3402
Fundamentals Value
Market Cap 309.07 Million
Num Shares 200 Million
EPS -3.40
Price-to-Earnings (P/E) Ratio -45.47
Price-to-Sales 759.00
Price-to-Book 24.66
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 167.35
Resistance 3 (R3) 165.93 160.27 165.23
Resistance 2 (R2) 160.27 157.02 160.98 164.52
Resistance 1 (R1) 157.43 155.01 158.85 158.85 163.81
Pivot Point 151.77 151.77 152.48 152.48 151.77
Support 1 (S1) 148.93 148.52 150.35 150.35 145.39
Support 2 (S2) 143.27 146.51 143.98 144.68
Support 3 (S3) 140.43 143.27 143.98
Support 4 (S4) 141.85